FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,846,470 | -55.0% | 183,000 | 0.0% | 0.36% | -55.8% |
| Q3 2022 | $4,101,000 | -9.6% | 183,000 | 0.0% | 0.81% | -11.6% |
| Q2 2022 | $4,535,000 | -39.4% | 183,000 | -5.3% | 0.91% | -31.2% |
| Q1 2022 | $7,489,000 | -33.7% | 193,160 | 0.0% | 1.33% | -21.9% |
| Q4 2021 | $11,302,000 | -1.3% | 193,160 | 0.0% | 1.70% | +78.7% |
| Q3 2021 | $11,449,000 | -10.3% | 193,160 | +31.4% | 0.95% | -7.8% |
| Q2 2021 | $12,758,000 | +8.6% | 147,000 | +3.2% | 1.03% | +15.8% |
| Q1 2021 | $11,749,000 | +30.5% | 142,500 | +43.9% | 0.89% | +40.5% |
| Q4 2020 | $9,002,000 | – | 99,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |